Lung cancer guidelines are inadequate for GPs
Studies funded by pharmaceutical companies do appear to be biased to company products, according to new research.
An analysis of studies presented at a medical conference found those sponsored by industry were significantly more likely to report in favour of a company product than those with other funding sources.
Of the 48 studies analysed, 30 were funded by pharmaceutical companies and 18 had no financial links.
All of those with ties to industry reported positive results but only two-thirds of those without links.
The findings were published in the American Journal of Medicine (December).